Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

TransMedics (TMDX) EPS (Basic) (2018 - 2026)

TransMedics has reported EPS (Basic) over the past 8 years, most recently at $3.1 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 1376.19% year-over-year to $3.1; the TTM value through Dec 2025 reached $5.6, up 418.52%, while the annual FY2025 figure was $5.6, 423.36% up from the prior year.
  • EPS (Basic) for Q4 2025 was $3.1 at TransMedics, up from $0.71 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $3.1 in Q4 2025 and troughed at -$0.78 in Q3 2023.
  • A 5-year average of $0.15 and a median of -$0.06 in 2023 define the central range for EPS (Basic).
  • Biggest five-year swings in EPS (Basic): tumbled 212.0% in 2023 and later surged 1376.19% in 2025.
  • Year by year, EPS (Basic) stood at -$0.46 in 2021, then surged by 56.52% to -$0.2 in 2022, then skyrocketed by 160.0% to $0.12 in 2023, then surged by 75.0% to $0.21 in 2024, then surged by 1376.19% to $3.1 in 2025.
  • Business Quant data shows EPS (Basic) for TMDX at $3.1 in Q4 2025, $0.71 in Q3 2025, and $1.03 in Q2 2025.